Home-based Cognitive Monitoring in MCI

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-12-01

Study Completion Date

2020-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is an observational study to confirm usefulness of a home-based cognitive monitoring in non-demented patients with high-risk of dementia

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Metacognition in Semantic Dementia: Comparison With Alzheimer's Disease

NCT04597827

Semantic Dementia Alzheimer Disease Healthy

COMPLETED

Pre-demential Motoric Cognitive Risk Syndrome in Ageing Subjects

NCT05640141

Motoric Cognitive Risk Syndrome Mild Cognitive Impairment Alzheimer Disease +1 more

UNKNOWN

App-based Cognitive Training at Home

NCT03494699

Healthy Volunteers, Aged

UNKNOWN NA

The Montreal Cognitive Assessment as a Screening Tool for Preoperative Mild Cognitive Impairment in Geriatric Patients

NCT01496222

Mild Cognitive Impairment

UNKNOWN

Assessing Cognitive Decline at Home

NCT06704971

Mild Cognitive Impairment Mild Dementia Dementia Alzheimers +3 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We prospectively enroll subjects who were diagnosed as mild cognitive impairment based on neuropsychological tests battery, brain MRI, and routine blood labs including thyroid function tests, vitamine B12 \& folate levels, and syphilis screening to rule out other secondary causes of dementia. We undergo peripheral blood-based amyloid beta levels and regular home-based cognitive monitoring (every 3 months) to investigate whether amyloid-positive MCIs progress rapidly using home-based cognitive monitoring during 6 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mild Cognitive Impairment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

high risk MCI

MCI patients with amyloid beta positive (based on peripheral blood level)

home-based cognitive monitoring

Intervention Type DIAGNOSTIC_TEST

a newly developed home-based cognitive monitoring (about 3-5 minutes per test; total score ranges from 0\~30; higher score indicates better cognition)

low risk MCI

MCI patients with amyloid beta negative (based on peripheral blood level)

home-based cognitive monitoring

Intervention Type DIAGNOSTIC_TEST

a newly developed home-based cognitive monitoring (about 3-5 minutes per test; total score ranges from 0\~30; higher score indicates better cognition)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.